Contrast-induced nephropathy: a clinical and evidence-based approach.
about
Imaging diagnosis of acute pulmonary embolism.Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data.Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic reviewContrast-enhanced ultrasonography with microbubbles for successful screening of kidney tumoursImage fusion for preoperative evaluation of vertebral artery in a patient with atlantoaxial vertical subluxation and chronic renal failure.Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CINEmbolization of hypervascular bone metastases reduces intraoperative blood loss: a case-control study.Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials.3D contrast enhancement-MR angiography for imaging of unruptured cerebral aneurysms: a hospital-based prevalence study.Reduction of circulating endothelial progenitor cell level is associated with contrast-induced nephropathy in patients undergoing percutaneous coronary and peripheral interventions.Oral salt and water versus intravenous saline for the prevention of acute kidney injury following contrast-enhanced computed tomography: study protocol for a pilot randomized trial.Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centreThe Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-AnalysisPreventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.Association of chronic renal insufficiency with in-hospital outcomes after percutaneous coronary intervention.Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.Low kV settings CT angiography (CTA) with low dose contrast medium volume protocol in the assessment of thoracic and abdominal aorta disease: a feasibility study.In vivo small animal micro-CT using nanoparticle contrast agents.Contrast-induced nephropathy--a review of current literature and guidelines.Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.Endovascular treatment of complex aortic aneurysms: prevalence of acute kidney injury and effect on long-term renal functionThe kidney in oncology.Contrast-induced nephropathy in the critically-ill patient: focus on emergency screening and prevention.Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography.Contrast medium-induced nephropathy: strategies for prevention.Computed tomography in patients with abdominal pain and diarrhoea: does the benefit outweigh the drawbacks?Contrast media-induced nephropathy: case report and review of the literature focusing on pathogenesis.CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy.Suboptimal implementation of diagnostic algorithms and overuse of computed tomography-pulmonary angiography in patients with suspected pulmonary embolism.Risk factors for contrast induced nephropathy: a study among Italian patients.Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization-A Population-Controlled Study.Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option?Pharmacological strategies to prevent contrast-induced acute kidney injury.Efficacy of statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis of randomised controlled trials.N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.Diagnosis and therapy of atheromatous renal artery stenosis.Nano-sized CT contrast agents.Incidence and outcome of re-entry injury in redo cardiac surgery: benefits of preoperative planning.
P2860
Q30443603-580E1DC7-E336-40C6-903A-DA4A7B0ADA01Q30487828-6A10CB37-7E41-42FC-84EE-A1683CB3A9A4Q30603357-09706751-AA66-4124-AF65-1EFE7AD3A18FQ31005347-FC77ABD5-805E-4269-9167-A37584E110F3Q33743880-269B9B22-10E7-4B01-8E77-FB0A4AEF6C72Q33816733-4295B896-DD0D-475B-9477-337C2D54ED64Q33973190-C01ADDDB-EEDF-455E-88FD-DCA600807041Q33995274-35711556-B0C3-48FE-9F55-2CE2D893503EQ34161406-DC31B05B-011A-4BDF-939A-21B7F7609062Q34236781-678F976B-E6BF-4D60-AEE8-13A94DF2812FQ34612298-B3CBF7F5-A6FF-4CC1-B437-E612837B10ECQ35124843-7F7DA1E2-D88C-44EB-8D3D-FBB6F154E194Q35440039-06A0C312-6D8D-4F4E-AFA1-0F0BE4AED8DBQ35593219-C47E53D4-F58C-41B6-9A41-D6A6D373F679Q35666177-2B131801-1551-4032-B071-6D814C7FCE7FQ35999430-9A74354F-1AD8-42D4-B485-1C3E7E4A322FQ36142053-612B2B26-AE79-4592-8759-5EFC1AC5D24DQ36151512-FA403F27-1423-4CF9-89C2-3C878A17772CQ36235487-86432009-A49A-439F-9098-0565FB596FC2Q36245557-5282B680-1F14-49FD-B52B-4E7EAE54C2DAQ36576632-0844807D-06D2-48DA-A446-D96A57B15AA5Q36804786-2E22058B-3EB7-4BEF-B422-CD637EDE5DA7Q36892262-31EFA38A-8E12-459D-8E30-09B58211D758Q36900332-CE0BEED8-C04C-41DE-BCCC-EAA4181E7A85Q37088294-538E5324-34AF-4D23-A5C9-EF8999958851Q37114007-4D48B104-AD3C-4266-B042-7ACD9D96941AQ37254460-9C95B9F6-95FA-4EB3-855A-DE17C8D3521CQ37294462-E335F5CD-111C-4027-9F14-F04D35BECA10Q37299311-6B9DB2BD-A890-4B1F-8162-514B945B1A0EQ37304873-1A521D8E-316E-4486-9709-7C75C3F69615Q37350569-987B18C2-F873-4DB7-8412-8543F1F4FBC6Q37387309-8E49008C-F1CA-459E-9957-D1695CA8BF96Q37434602-6B49476E-F446-4730-845D-C0C69CEB9841Q37524154-0B7E688B-A90F-443B-833E-4FAE69A23221Q37639849-9EDBE6F8-C199-4235-A107-D0A1513ED222Q37864718-1F29B81A-2076-4E46-A6EA-960BD7CDF794Q37977061-921F57AA-F8BD-4B54-B4EC-138884A5FF78Q38093091-5619F643-FF4C-44BA-85D4-49AECD5AD35CQ38095868-B4B70D35-052D-46C3-A184-52D6EFAB681BQ38227823-382D36F3-17C6-4215-8037-45AB2DBCBEDF
P2860
Contrast-induced nephropathy: a clinical and evidence-based approach.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Contrast-induced nephropathy: a clinical and evidence-based approach.
@ast
Contrast-induced nephropathy: a clinical and evidence-based approach.
@en
type
label
Contrast-induced nephropathy: a clinical and evidence-based approach.
@ast
Contrast-induced nephropathy: a clinical and evidence-based approach.
@en
prefLabel
Contrast-induced nephropathy: a clinical and evidence-based approach.
@ast
Contrast-induced nephropathy: a clinical and evidence-based approach.
@en
P2093
P1433
P1476
Contrast-induced nephropathy: a clinical and evidence-based approach.
@en
P2093
Martin Tepel
Norbert Lameire
Peter Aspelin
P304
P356
10.1161/CIRCULATIONAHA.105.595090
P407
P577
2006-04-01T00:00:00Z